¿Û¿Û´«Ã½

UK chipmaker EnSilica moves back into profit

The microchip company now possesses significant operational leverage

New contract wins are making this medtech a takeover target

Simon Thompson: The group’s US business is starting to deliver and a large shareholder is increasing its stake

This US stock’s IPO offers a cracking entry point

Simon Thompson: As American investors become aware of the company’s potential, the dual-listed shares will re-rate

CAB Payments turns down £213mn takeover approach from former owner

The private equity consortium that still holds 45 per cent of the company wants to take it private again

This company can’t stop beating earnings guidance

Simon Thompson: It posted a 16 per cent earnings beat, but only trades on a PE ratio of 12

Crest Nicholson returns to profit

Profitability may improve further from the second half of 2026

Scancell gets FDA green light for phase 3 melanoma trial

The immunotherapy specialist’s pipeline is about to enter a critical phase

ITM Power makes progress towards profitability

The green hydrogen specialist should have enough cash to see it through to break-even

Bank this small cap’s high yield and low rating

Simon Thompson: Analysts are upgrading earnings estimates, and a tender offer is being pitched at a healthy premium

Ecora ponders next move after share price rise 

Royalty company’s valuation has soared as investors rethink its new base metals portfolio